ArticleGenetics and molecular biology2026
Reconstruction of the evolutionary landscape of biological processes involved in the early stages of the metastatic cascade.
Article in Genetics and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metastasis is not a de novo functional module innovation but rather the pathological redeployment of deeply conserved biological programs. Here, we reconstruct the evolutionary landscape of biological functions involved in the early stages of the metastatic cascade, including cell adhesion, extracellular matrix organization (ECM), regulation of metallopeptidase activity, cell junction organization, epithelial-mesenchymal transition (EMT), and cellular extravasation alongside the physiological constraints that suppress them (Metastasis Suppressor Genes). Using phyletic pattern reconstruction of 787 orthologs across 473 Clusters of Orthologous Groups with the Bridge algorithm, we identified a divergence between the evolutionary timelines of metastasis-enabling programs and metastasis suppressors. Our results indicate that the molecular systems associated with the structural capacity for tumor dissemination are evolutionary ancient. ECM organization traces to the Human-Discoba last common ancestor, EMT to Ctenophora, cell adhesion to Sauropsida, and cellular extravasation to Actinopterygii. In contrast, mechanisms responsible for suppressing genomically unstable cells during continuous tissue renewal emerged later, peaking in the vertebrate lineage. These findings support the Serial Atavism Model and suggest that metastasis arises from the progressive erosion of recently evolved regulatory constraints, allowing the reactivation of ancestral cellular programs that predate complex multicellularity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.